Reading time is 3 mins
.
.
DISEASE X IS A PROJECT DEVELOPED AGAINST THE 11 DEADLIEST VIRUS OUTBREAKS
Turkey Medicals Co-ordinator, “IAU VW MedicalPark Florya hospital infectious diseases and microbiology specialist Dr. Teach member underlined that the studies conducted on disease x ensure that the whole world reacts quickly during the covid pandemic.”
The term disease X was coined years ago by scientists to provide research on medical measures against unknown infectious threats, rather than known threats such as the Ebola virus, said Dr. Teach, member of the WHO Research and Development plan, said, “Among the dangerous viruses included in the list of WHO’s R&D plan are Covid-19, Crimean-Congo hemorrhagic fever, Ebola virus disease and Marburg virus disease, Lassa fever, MERS and SARS, Nipah and henipaviral diseases, Rift Valley Fever and Zika.
The X Disease, which was first placed on the World Health Organization’s (WHO) priority pathogens list in 2017, was first raised by World Health Organization Director-General Tedros Ghebreyesus at the World Economic Forum held in Davos, Switzerland.
IAU VM Medical Park Florya Hospital Infectious Diseases and Microbiology Specialist Dr. Who made a statement on the subject. Teach, Member of the X Disease, underlined that studies on the X Disease ensure that the whole world reacts quickly in the Covid pandemic, “The term X Disease was coined years ago to enable scientists to work on medical measures against infectious threats such as the new coronavirus, which causes unknown Covid-19, instead of known threats such as the Ebola virus. The aim is to encourage the development of technologies that can be quickly adapted and deployed in response to situations with the potential for epidemics or pandemics in the future, including vaccines, drug treatments and diagnostic tests,” she said.
What is X disease?
Dr. Teach Member “X disease is a name given to a disease caused by a currently unknown, but serious microbial threat. In 2017, the World Health Organization added Disease X to the shortlist of top priority pathogens for research, alongside known killers such as Severe Acute Respiratory Syndrome (SARS) and Ebola,” the World Health Organization said in a statement.
“Covid-19 was an example of disease X”
The Covid-19 virus, caused by a new coronavirus, was an example of Disease X when it started the pandemic at the end of 2019, said Dr. Teach Member Alış said, “The vast virus reservoir in nature is seen as the source of such diseases. This is because viruses have the potential to spread and infect other living species, including humans, and lead to an infection that humans cannot become immune to,” she said.
“It is used for unknown diseases”
Underlining that one of the tasks of WHO is to provide R & D as a preliminary preparation for unknown diseases, Dr. Teach Member Alış said, “The humanitarian crisis caused by the 2014-2016 Ebola epidemic in West Africa was a wake-up call. Despite decades of research, there were no readily available products that could be used in time to save more than 11 thousand lives. On top of this, WHO has established an R & D plan to accelerate the development of a range of tools for ‘priority diseases’,” she decried.
“List of the most dangerous viruses”
Dr. Teach Member Alış explained the dangerous viruses included in the current list of WHO’s R & D plan as follows: “Covid-19, Crimean-Congo hemorrhagic fever, Ebola virus disease and Marburg virus disease, Lassa fever, Middle East respiratory syndrome (MERS) and SARS, Nipah and henipaviral diseases, Rift Valley Fever, Zika. Crimean-Congo hemorrhagic fever, Ebola virus disease and SARS.”
“New treatments are being developed”
Expressing that the studies of Disease X have accelerated the reaction against Covid, Dr. Teach Member Alış said, “The period from the publication of the genetic sequence of the SARS-CoV-2 virus to the approval of the first Covid vaccine took only 326 days. We owe all this to the Disease X studies conducted since 2017. Now groups such as the Coalition for Epidemic Preparedness Innovations, or CEPI, are supporting rapid response vaccine platforms that can develop new vaccines within 100 days of the appearance of a pandemic-potential virus under a $3.5 billion plan,” she said.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.